Eloxx Pharmaceuticals (@eloxx_pharma) 's Twitter Profile
Eloxx Pharmaceuticals

@eloxx_pharma

Clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates to treat rare and ultra-rare premature stop codon diseases.

ID: 1281355319185215488

linkhttps://www.eloxxpharma.com/ calendar_today09-07-2020 22:31:38

74 Tweet

176 Takipçi

32 Takip Edilen

Eloxx Pharmaceuticals (@eloxx_pharma) 's Twitter Profile Photo
Eloxx Pharmaceuticals
@eloxx_pharma

a year ago

Not all types of Alport syndrome are the same. Patients w/ certain mutations progress to end-stage renal disease faster than others. At Eloxx, we’re working to address the most serious forms of #Alportsyndrome. Learn more about our focus in this area: lnkd.in/g3EeFMzp

Not all types of Alport syndrome are the same. Patients w/ certain mutations progress to end-stage renal disease faster than others. At Eloxx, we’re working to address the most serious forms of #Alportsyndrome. Learn more about our focus in this area: lnkd.in/g3EeFMzp